Classward LLC

The RxEd Podcast

Education EN ↓ 30 episodes

The RxEd Podcast is a continuing education podcast for pharmacy professionals who want learning that actually translates to practice. Hosted by pharmacists Kaitlyn Morrill, PharmD, and Travis Frost, PharmD, and presented by  PharmRenew.com , the show connects accredited continuing education with the realities of day-to-day pharmacy practice — from patient safety and clinical decision-making to professional growth and the evolving role of the pharmacist. How to earn CE credit: To receive credit, pharmacy professionals must access the episode on  PharmRenew.com , complete the required learning a...

Be sure to visit the podcast's website and support the creator: TheRxEdPodcast.podbean.com

Author

Classward LLC

Category

Education

Podcast website

TheRxEdPodcast.podbean.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Shorts: Statin Muscle Symptoms and the Nocebo Effect: A Practical Approach to Intolerance 17.11.2026

“I stopped my statin because my legs ached, and they felt better once I quit.” Sounds open and shut, but feeling better after stopping doesn’t prove the statin was the cause. This short covers what the research really says about statin muscle symptoms, including where the nocebo effect fits in (and where it doesn’t), plus the warning signs that mean holding the statin and getting urgent evaluation...

Beyond Weight Loss and Blood Sugar Control: The Expanding Therapeutic Reach of GLP-1 Receptor Agonists 16.11.2026

Where GLP-1 receptors are, what they do beyond appetite, and why organ protection can't be explained by weight loss alone. This episode covers a number of weight-independent mechanisms, the design and findings of important clinical trials, and how to tell weight-driven benefit from a direct drug effect across disease states.

Shorts: Defusing Conflict: A Pharmacy Technician's Guide to De-escalation 12.11.2026

"What do you MEAN it's not covered?!" Every technician has heard it — and most learn the hard way that a calm, logical explanation often makes an angry patient angrier. This short covers why that happens, the communication habits that build or erode patient trust, and five de-escalation techniques you can use at the counter. Plus when to escalate to the pharmacist, and the safety rules that take p...

Shorts: DIR Fees & 340b, In Plain English 10.11.2026

DIR fees and 340B, explained without the acronym soup. Where the money actually moves, who's holding the cash in the meantime, and why a pending shift from upfront 340B discounts to after-the-fact rebates has safety-net providers and contract pharmacies worried about January 2027.

Shorts: First Set of Eyes: Spotting Fraudulent Prescriptions at the Counter 05.11.2026

A new patient slides an oxycodone prescription across the counter and offers to pay cash. Nothing about that is illegal — but a flag just went up. This short covers how prescription fraud actually shows up at drop-off: red flags in the patient and the situation, deviations from your prescribers' normal patterns, and the forgery tells to look for on the paper itself. Most importantly, it clarifies...

Shorts: Serotonin Syndrome: Drug Interactions, Clinical Signs, and Management Strategies 03.11.2026

Serotonin syndrome, from prescription to presentation. The interaction pairs that matter most, the triad of clinical findings that identifies it, the look-alikes it gets confused with, and why the timeline — hours, not days — is one of the most useful clues you have.

Shorts: Compounding Basics: Beyond-Use Dating and Why It Matters 29.10.2026

A vial can look perfect — clear solution, no particles, intact glass — and still be unsafe to use. Contamination doesn't announce itself. This short covers what a beyond-use date actually is and why it isn't an expiration date, how USP <795> and <797> set default limits, and why the environment where you compound drives how long a preparation lasts. Plus the vial clocks technicians man...

Shorts: Quitting Smoking & RA: A Short-Term Paradox with a Long-Term Payoff 27.10.2026

She quit smoking and her joints got worse. It's a real phenomenon with a plausible mechanism — and it's also the moment patients are most likely to relapse. A short look at why RA can flare after cessation, and how to counsel through it without undercutting the quit.

Shorts: Handle With Care: USP ⟨800⟩ and Hazardous Drugs for Pharmacy Technicians 22.10.2026

USP ⟨800⟩ from the technician's perspective. What counts as a hazardous drug and why it's broader than chemo, what the 2024 NIOSH list changed, where exposure actually happens during receiving and transport, PPE that meets the standard, the four-step cleaning sequence, and why medical surveillance exists. Ten minutes, built around the routine tasks where PPE gets skipped.

Shorts: FDA Approval of Rasonque: The First Broad RAS-Targeted Therapy in Pancreatic Cancer 20.10.2026

The FDA has approved Rasonque (daraxonrasib), the first targeted therapy designed to directly inhibit RAS, the protein driving the vast majority of pancreatic cancers. In this episode, we break down how this once-daily oral RAS inhibitor works, the Phase 3 data that nearly doubled overall survival compared with chemotherapy, and who qualifies under the new label.

Shorts: Never Break the Chain: Cold Chain Compliance for Pharmacy Technicians 15.10.2026

A medication travels thousands of miles under perfect conditions — then arrives at your counter. This ten-minute episode covers what happens next: refrigerator do's and don'ts, digital data logger specs and daily log review, loading the fridge for airflow and FEFO, temperature mapping, and the power-outage sequence. Because temperature damage is invisible, and the vial always looks fine.

Shorts: Counseling the GLP-1 Patient 13.10.2026

What to say when a GLP-1 patient walks up to the counter. Titration expectations, managing GI side effects before they derail therapy, injection technique, missed doses, and the honest conversation about what happens when treatment stops.

What We Miss: Human Trafficking Awareness and the Role of the Pharmacist 12.10.2026

Trafficking victims come through pharmacy doors, and almost no one recognizes them. This course covers the legal definitions, the myths that block identification, the physical, behavioral, environmental, and prescription-pattern red flags, the PEARR framework for approaching someone safely, and the reporting obligations that differ for minors and adults. Includes three vignettes with embedded disc...

Shorts: Common Reject Codes: A Technician's Field Guide 08.10.2026

A reject code tells you which field or rule the plan objected to — but not whether it's yours to fix. This episode covers how claim adjudication works, what M/I codes mean, and which of the common NCPDP rejects point to correctable claim data versus a coverage rule needing payer or prescriber action. Including why "refill too soon" often traces back to the last fill.

Shorts: From Gut to Brain: The Science Behind GLP-1 Medications 06.10.2026

Why does a gut hormone quiet appetite in the brain? A short tour of GLP-1 physiology — where it's secreted, what DPP-4 does to it, how the drug versions escape that fate, and where the receptors that drive satiety actually live.

Shorts: Prescription Data Entry: The Errors That Cause Rework 01.10.2026

Most medication errors don't start at the counter — they start at the keyboard. This episode walks through the data entry screen from the top: patient identifiers and why you never edit a DOB to clear a reject, allergies and drug–disease interactions, look-alike drug names, high-alert strengths, and the prescriber fields everyone skips. Plus the five-category checklist to run before you hit enter.

Shorts: Not Just Kratom: Understanding 7-OH Regulation 29.09.2026

Kratom and 7-OH aren't the same thing — and the DEA's action only targets one of them. This episode unpacks the July 2026 notices of intent to temporarily place concentrated 7-hydroxymitragynine and three synthetic analogues into Schedule I, why the 0.05% threshold matters, what's left untouched, and where the federal timeline actually stands. Plus the state-level patchwork that's already in effec...

Shorts: The Expanding Technician’s Role in Immunization 24.09.2026

The technician's role in immunization changed fast — six states permitted technician vaccinators in 2020, and 47 plus DC did by 2025. This episode covers what drove that shift, the PREP Act authority now extended through 2029, the APhA/WSU training and PTCB certificate paths, and the operational work technicians run even where they don't administer. Plus why state rules, not federal, govern your p...

Shorts: Flu, COVID, & RSV: The 2026-7 Respiratory Vaccine Lineup 22.09.2026

Flu, COVID, and RSV in one sitting — here's the 2026–2027 lineup. New flu strains across the board, an updated COVID formula, and RSV recommendations that now reach down to age 50 for high-risk adults. A quick map of who's eligible for what heading into respiratory season.

Shorts: The 2026-2027 Flu Shot in 5 Minutes: New Strains, Same Counseling Questions 17.09.2026

Five minutes, one season's worth of changes. All three strains in the 2026–2027 flu vaccine were updated from last season — new H1N1, H3N2, and B/Victoria components — after a rough year for vaccine match. We cover what's actually different in this year's formulation, and then the part that never changes: the same handful of counseling questions patients ask at the counter every single fall, and h...

Shorts: Moderna & Merck’s Personalized mRNA Melanoma Vaccine 15.09.2026

For the first time, an mRNA cancer therapy has succeeded in a Phase 3 trial. Merck and Moderna's intismeran autogene — a vaccine built from a patient's own tumor mutations — improved recurrence-free and distant metastasis-free survival when added to Keytruda in high-risk melanoma. We look at why this result is being called a landmark, touch on how mRNA teaches the immune system to hunt cancer cell...

The Incretin Era: What You Need to Know About GLP-1 and Dual Agonist Agents 14.09.2026

Mechanism, menu, and counseling for the GLP-1 class. This episode covers how these agents work, the established injectables and their brand-and-dose pairs, the new oral options, including the first nonpeptide pill, head-to-head weight-loss data, and why two-thirds of patients stop within a year.

Point-of-Care Testing: A Practical Guide for Community Pharmacy 17.08.2026

In this episode of the RxEd Podcast, we explore point-of-care testing in community pharmacy and how pharmacists can use rapid testing to expand access to timely, evidence-based patient care. Listeners will examine the regulatory framework surrounding CLIA-waived testing, the clinical interpretation of common point-of-care tests, and the practical considerations involved in building sustainable tes...

Dispensing Buprenorphine: Communication Skills for Difficult Pharmacy Interactions 13.07.2026

In this episode of the RxEd Podcast, we explore best practices for dispensing buprenorphine with a focus on patient-centered communication, stigma reduction, and supporting individuals receiving treatment for opioid use disorder (OUD). Listeners will review the role of buprenorphine in medication treatment for OUD, common barriers patients face when accessing therapy, and how effective communicati...

Psychedelic Medicine: From Ancient Healing to Modern Healthcare Innovation 15.06.2026

In this episode of the RxEd Podcast, we explore the growing field of psychedelic medicine in the United States and its potential impact on healthcare. Listeners will learn about the history of psychedelic therapies, current research into their therapeutic applications, and the evolving regulatory landscape surrounding these treatments. The episode examines emerging evidence for the use of psychede...

Listen to the The RxEd Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.